Company / Financials
Orthofix Medical Inc. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$746.6M
FY2025 · +62.1% YoY
Net Income
-$151.4M
FY2025 · -666.6% YoY
Profit Margin
-20.3%
FY2025 · net income / revenue
ROE
-30.1%
FY2025 · return on equity
Total Assets
$850.6M
FY2025
Total Debt
$157.4M
0.31x debt/equity
Equity
$503.1M
FY2025
ROA
-17.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$746.6M+62.1% YoYNet Income HistoryProfit after all expenses and taxes-$151.4M-666.6% YoYGross Profit HistoryRevenue minus cost of goods sold$486.3M+44.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$260.4M+110.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$139.1M-948.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$530.4M+71.8% YoYR&D Expense HistoryResearch and development spending$80.2M+63.5% YoYInterest Expense HistoryCost of borrowing and debt obligations-$8.6M-570.1% YoYIncome Tax HistoryTotal income tax expense$2.7M+32.9% YoYEPS (Basic) HistoryBasic earnings per share-$4.12-320.4% YoY